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The present study evaluated whether the unilateral 6-hydroxydopamine (6-OHDA) model of Parkinson’s disease produces
autonomic deﬁcits. Autonomic parameters were assessed by implanting a small radiofrequency telemetry device which measured
heart rate variability (HRV), diurnal rhythms of heart rate (HR), core body temperature (cBT) and locomotor activity (LA). Rats
then received 6-OHDA lesion or sham surgery. 6-OHDA lesioned rats exhibited head and body axis biases, defective sensorimotor
function (“disengage” test), and prominent apomorphine rotation (all P<. 05 versus controls). Diurnal rhythm of HR was lower
for 6-OHDA lesioned rats (n = 8) versus controls (n = 6; P<. 05). Whilst HR decreased similarly in both groups during the
day, there was a greater decrease in HR for the 6-OHDA lesioned rats at night (by 38b.p.m. relative to 17b.p.m. for controls). LA
and cBT did not diﬀer between surgery groups. This study indicates the unilateral 6-OHDA model of PD shows subtle signs of
cardiovascular autonomic dysfunction.
1.Introduction
Parkinson’s disease (PD) is a progressive neurological dis-
order, characterized by the symptoms of resting tremor,
rigidity, postural instability, gait disturbances, and slowness
of movement [1, 2]. Overt clinical symptoms of the disease
are not apparent until there is a loss of 70% of nigral
neurons and 80% of striatal dopamine [3, 4]. The dopamine
precursor, levodopa continues to be the main treatment
of PD, and it is highly eﬀective for treating the motor
symptoms. However, current treatments are ineﬀective in
treating the other disruptive symptoms of the disease [5, 6].
Recent studies have reported that up to 80% of PD patients
experience autonomic dysfunction to varying degrees [7–9]
of which cardiovascular symptoms attract the most clinical
interest as these are the most likely to lead to serious compli-
cations, even death [7]. Other autonomic symptoms of PD
include gastrointestinal and thermoregulatory/sudomotor
symptoms, urinary and sexual dysfunction, as well as sleep
and respiratory disorders [7–9]. There are also alterations in
the circadian rhythms of blood pressure with greater diurnal
variability and the presence of postprandial hypotension
[10]. Furthermore, there is a growing body of experimental
and clinical evidence suggesting that the basal ganglia plays
not only a role in the control of motor function, but also
autonomic activity [9].
Animal models have been widely used to give insights
into the pathophysiology of PD (for reviews, see [11, 12]).
In the rat, the dopaminergic substantia nigra (SN) may be
destroyed by lesioning the nigrostriatal tract via the medial
forebrain bundle (MFB) using an analogue of dopamine,
6-hydroxydopamine (6-OHDA). This is the most common
model and has been found to eﬀectively mimic the degree
of dopaminergic cell loss and some motor symptoms of PD
[11–13].
Limited recent studies have shown that animal models
of PD do exhibit some autonomic dysfunction, such as
alterations in diurnal rhythm (decreased thermoregula-
tory function), sleep disorders, and dysfunctions in blood
pressure regulation [14–16]. However, these studies used
bilateral 6-OHDA animal models of PD, and lesioned a
diﬀerent area to the MFB [14–16]. The bilateral model is less
commonly employed by researchers as the animals generally
exhibit severe aphagia, adipsia, loss of body weight, and
greatly increased mortality during the day after surgery [11],
serious health issues which do not occur in the unilateral2 Parkinson’s Disease
animal model [17]. A bilateral striatal lesion model, however
has been created which exhibits >80% striatal dopamine
depletion and minimal mortality [18]. The unilateral 6-
OHDA model is used in the present study as it is the most
widely utilised model for the experimental study of PD in
rats [19]. Whilst one study found an increase in Q-T interval
via short-term ECG [19], to date, no studies have performed
chronic telemetric analysis assessing heart rate variability
or diurnal rhythm in this model. For these reasons, the
present study was designed to assess whether rats with a
large unilateral 6-OHDA lesion of the MFB exhibit evidence
of autonomic deﬁcits. The presence of autonomic deﬁcits
was assessed by implantation of a small radiofrequency
telemetry device which measured heart rate (HR), core body
temperature (cBT), and locomotor activity (LA). Telemetry
has previously been shown to be an eﬀective measure of
autonomic nervous system activity in the rat [14, 15, 20].
2. Methods
2.1. Animals. Forty Female Sprague-Dawley rats, weighing
approximately 200–260g and aged 10–12 weeks old on
arrival, were housed in 20 pairs (cages: 30 × 40 × 16cm),
with standard rat chow and water available ad libitum.
Temperature was controlled at 21.5 ± 1◦C, with a light-
dark cycle (12:12 hrs, light from 07:00 to 19:00, dark from
19:00 to 07:00). The experiments were conducted with
ethicalapprovalfromtheAnimalCareandEthicsCommittee
of the University of Sydney, Australia, and conducted in
accordance with Australian National Health and Medical
Research Council’s Guidelines on the Use and Care of
Animals in Research (1997).
2.2. Experimental Timeline. Rats were acclimatised for one
week with gentle handling before beginning behavioral test-
ingforaperiodof2-3weeks.Theratsweighedapproximately
285g at the time of telemetry surgery and subsequent
unilateral6-OHDAlesions.Theheavierofthetwocagemates
underwent telemetry surgery (week 4). Rats were given
one week to recover from surgery (week 5), after which
postoperative measurements of behavioral parameters and
telemetry data were recorded for a week (week 6). 6-OHDA
lesion surgery was then performed, and a further two weeks
of behavioral testing was carried out (week 7 & 8) during
which telemetry data was also recorded (Figure 1).
2.3. Techniques
2.3.1. Behavioral Testing. Tests were carried out once per
week as (1) baseline measurements for 1–3 weeks before
telemetry surgery; (2) measurements one week after teleme-
try surgery; then, (3) for two weeks following MFB surgery.
These tests were carried out on both control and lesioned
animals with each animal being tested in a clean test cage.
(1) Observation of Head Position. Brieﬂy, the rat was allowed
to habituate to the test cage, and head position (>10◦
deviation left or right from midline, or neutral) was noted
Rats arrive week 1,
baseline behavioral
tests weeks 2 & 3
(n = 40)
Telemetry surgery
week 4; further
behavioral tests
early week 6
No telemetry surgery
week 4; further
behavioral tests
early week 6 (n = 16)
6-OHDA surgery
week 6; further
behavioral testing
w e e k s7&8( n = 8)∗
Sham surgery week
6; further
behavioral testing
w e e k s7&8( n = 6)∗
No surgery week 6;
further behavioral
testing weeks 7 & 8
(n = 16)∗
Figure 1: Flow chart illustrating study design. Note that whilst
40 rats were employed, 10 were excluded due to either surgical
complications or mistargeting of the 6-OHDA lesion. ∗ﬁnal
number employed in data analysis.
every second for 60s in triplicate following the tick of a
watch [13, 21]. Net head position bias was calculated as the
total number of seconds head position was held ipsilaterally
minus the total number of seconds head position was held
contralaterally over a total of 180s [13, 21].
(2) Curling. This test is a modiﬁcation of the elevated body
swing test, as described previously [21, 22]. Brieﬂy, rats were
gently suspended for 5s by the base of the tail over the
empty test cage ﬂoor with the paws 2cm above the ﬂoor.
Curling direction bias was noted as a deviation of ≥10◦
from the vertical axis. An ipsilateral turn was recorded as
+1, a contralateral turn as −1, and no turn as 0. Severity
was expressed on a scale of 0 to 3 (i.e., 0 = no curling, 1 =
mild (10–60 degrees), 2 = moderate (>60–120 degrees) and
3 = severe (>120 degrees) curling). Testing was performed in
triplicate on each test week.
(3) Sensorimotor and Disengage. This test was carried out
as previously described to measure sensorimotor deﬁcit as a
result of nigrostriatal dopamine depletion induced by the 6-
OHDA lesion [21]. The left and right vibrissae were touched
by a probe, and the sensorimotor response (conducted in
the absence of chocolate) latency was measured using a
stopwatch and involved either moving or touching the probe
with mouth, snout or paw [21]. This was then repeated for
the “disengage” test whilst the rat was eating a 2.5g piece of
chocolate [13].
(4) Apomorphine Rotation. Rats were injected with apomor-
phine to test rotational asymmetry [21]. Prior to sacriﬁce,
rats were injected subcutaneously with 0.2 mg/kg apomor-
phine hydrochloride (Sigma, Steinheim, Germany) dissolved
in 1% ascorbate saline solution. 10 minutes after injecting,
rats were placed into a white, hemispheric, plastic rotation
bowl(42cmwideattopand22cmdeep)andrecordedfor30
minutes using a DVD camera. The recording was manuallyParkinson’s Disease 3
scored and net contralateral turning bias calculated (number
of contralateral minus number of ipsilateral turns) [11].
2.3.2. Telemetry
(1) Telemetry System. HR, LA, and cBT were recorded
by means of a telemetry system. This consisted of an
implantable radiotransmitter (model TA11-CTA-F40, Data-
Sciences International, St. Paul, MN, USA), a radio receiver
(model RPC-1, DataSciences) to receive telemetered signals,
a data exchange matrix to multiplex multiple cage signals to
the computer, and a computer-based data acquisition system
(Dataquest Silver version 3.0, DataSciences). The receiver
detected the radio waves and rodent activity as counts and
also the calibrated cBT, data which were registered in the
computer system.
(2) Telemetry Surgery. Transmitter implantation was carried
out under aseptic conditions with some modiﬁcation of
the technique described by Kramer and colleagues [23].
18 rats were anaesthetised with a mixture of 75mg/kg
ketamine and 10mg/kg xylazine (i.p.) and placed on a sterile
drape covering a heating mat (physiological temperature), to
prevent hypothermia. Brieﬂy, a midline incision of 2-3cm
was made, with two more incisions (1cm each) made at the
upper right chest and lower left leg to expose the muscle
tissue. The transmitter was inserted into the peritoneum and
the ECG leads extended subcutaneously to the right upper
rib area and the lower left leg and sutured to muscle tissue
there. The skin (abdomen, leg, and chest) was sutured closed
with absorbable suture and cleaned. Prophylactic broad-
spectrum antibiotics (5mg/kg enroﬂoxacin, s.c.) and pain
relief (0.05mg/kg buprenorphine, s.c.) were administered,
and warmed sterile saline (2.mL, i.p.) was administered
to replace ﬂuid lost during surgery. Rats were intensively
monitored during the next 24 hours postoperatively for any
adverse eﬀects.
2.3.3. Unilateral 6-OHDA Lesions. Eighteen rats under-
went stereotactic surgery, as described previously [13, 21].
Rats (n = 7) were initially anaesthetised using a mixture
of ketamine/xylazine (75mg/kg ketamine hydrochloride
Ketavir, Delvery, NSW, Australia plus 10mg/kg xylazine
hydrochloride, Ilium Xylazil-20, Troy Laboratories, NSW,
Australia, given i.p.) but due to better control of depth of
anaesthesia the remainder were anesthetised using isoﬂurane
(4% induction, 2% maintenance dose, n = 11) in oxygen
(1.5L/min). Rats were secured in a Stoelting stereotactic
frame (Lab Standard model 51600, Stoelting Co., Wood
Dale, IL, USA), using 45◦ nonpuncture earbars with the nose
bar positioned 2.3mm below the interaural line. 4μg/μLo f
6-OHDA (H 8523, Sigma-RBI, St. Louis, MO, USA) in 0.1%
ascorbate saline solution, was delivered at a rate of 1μL/min
for four minutes (via a 25-26 gauge Hamilton microsyringe
mounted vertically onto the stereotactic frame) unilaterally
into the medial forebrain bundle (MFB) in 12 rats (co-
ordinates: AP −4.4mm and L ±1.1 m mf r o mb r e g m a ,V
−8.0mmfromdura)[24]. Sham operated controls (n = 6),
received only vehicle solution. Buprenorphine (Temgesic,
Reckitt-Benckiser, Hull, UK) was given prophylactically for
analgaesia (0.05mg/kg s.c.).
2.3.4. Collection of Tissue
(1) Histology. Two weeks after 6-OHDA surgery the rats
were culled by terminal anaesthesia with halothane, then
perfused with 0.9% saline followed by 4% paraformaldehyde
in phosphate buﬀered saline (PBS). Brains were rapidly
removed from the skull and placed into paraformaldehyde
(4% buﬀered solution) overnight. They were transferred to
30% sucrose solution for 2 days for cryoprotection. Brains
were sliced on a Leitz 1320 (Wetzler, Germany) freezing
sledge microtome at 48μm intervals, generating 5 series.
One series was mounted onto gelatinised slides and stained
for cresyl violet, which allowed visualisation of the needle
tract. A parallel series was used for conﬁrming 6-OHDA
lesions by immunohistochemical staining of the tissue with
tyrosine hydroxylase, as described previously [13]. Multiple
serial sections were viewed under a binocular microscope
at 20× using a 10× objective. This enabled loss of both
dopaminergic nigral and striatal terminals to be visualised.
Size of 6-OHDA lesions was quantiﬁed by viewing multiple
serialTH-stainedsections(spaced240μmapart)throughout
the entire extent of the nigra under a microscope using a
10 ×10 grid eyepiece (of 2.49mm2 area). The total neuronal
number was estimated bilaterally. By comparing TH-stained
cell numbers between the lesioned and intact side of the
brain, the % cell loss (lesion size) was calculated [13].
2.4. Data Analysis
2.4.1. Telemetry Data Acquisition and Analysis. Telemetry
data was collected 24 hours a day, for 10s every 5 min-
utes, using the Dataquest acquisition program. For diurnal
rhythm data of HR, LA, and cBT, data was processed in
Excel and an average was calculated for day/night periods
(light/dark, 12:12h). Data was taken from 3 days before the
6-OHDA lesion/sham MFB surgery and for a further 13
daysafterwards.Amplitude(nightminusday)wascalculated
from this data, and for this postlesion data was normalised as
a percentage of mean prelesion data.
HR data continuously sampled for the 24 hours period
prelesion and a 24 hours period in the second week postle-
sion was compared. Oﬄine ECG analysis was performed
using Chart version 5 (AD Instruments, Australia), with
digital ﬁltering of 20–40Hz.
2.4.2. HRV Analysis. 24 hours periods of data pre- and
postlesion data were divided into 12 hours periods, to com-
pare day-night rhythms. Before analysis, data was collated in
Chart and artefact removed to reduce potential sources of
error (e.g., extra detection of RR intervals [25]).
2.4.3. Time and Frequency Domain Analysis. Time domain
parameters quantiﬁed were (1) the mean N-N interval dura-
tion (i.e., the average time distance between two consecutive4 Parkinson’s Disease
heart beats (NN, ms)), (2) average heart rate (b.p.m.), (3)
the standard deviation of NN (SDNN, ms), and (4) the root-
mean-square of successive R-R interval diﬀerences (RMSSD,
ms). HRV parameters are derived from direct measurements
of normal-to-normal (N-N) R-R. SDNN is the simplest
estimateofoverallHRV.Itisaglobalparameterofvariability,
which reﬂects all the cyclic components responsible for
variability in the period of recording (including short-term
low frequency and high frequency variations) [26, 27].
RMSSD is another common measure [27].
Frequency domain methods provide analysis of power
spectral density, which previously has been successfully used
to analyse autonomic nervous system function in rats [20].
HRV spectral bands were deﬁned as very low frequency
(VLF, 0–0.2Hz, ms2), low frequency (0.2–0.9Hz, ms2), and
high frequency (0.9–2Hz, ms2). Total power and the LF-
HF ratio were also calculated. The latter is considered to
be a convenient index of parasympathetic and sympathetic
interactions in the rat, whilst total spectral power ranges
from 0.0 to 2Hz and reﬂects the global spectral density [28].
2.4.4. Chronobiology Analysis of Heart Rate. Data from day
and night recordings were combined to give 24-hour periods
for frequency analysis. An hourly average of a 10 second
recording of HR was obtained for chronobiological analysis.
Fourier spectrum analysis using Microsoft Excel Fourier
Analysis was performed to establish the dominant frequency
and its’ periodicity.
The single cosinor method was used to ﬁt a cosine
function to the values which determined mesor (mean
value), amplitude (nadir diﬀerence), and acrophase (hour
of detection of the peak) for the recordings as previously
detailed [14].
2.4.5. Statistical Analysis. Data was statistically analysed
using StatView version 5 (SAS, USA). P<. 05 was taken as
signiﬁcant. Results are expressed as mean ± SEM.
Head position, curling, and sensorimotor and disengage
tests were each analysed using two-way repeated measures
analysis of variance (ANOVA) and post hoc Scheﬀe’s test
for group diﬀerences [13]. ANOVA was used to detect
diﬀerences in the magnitude of dopaminergic cell loss
between groups. Apomorphine rotation test was analysed via
student’s t-test (6-OHDA lesioned vs pooled control groups)
[13].
Normalised amplitude and data for time- and frequency-
domain measures was statistically analysed in StatView using
repeated measures of variance (ANOVA) and Scheﬀe’s post
hoc test. Postlesion data for diurnal rhythm was normalised
by taking a mean of the prelesion data, and calculating
the postlesion data as a percentage of this. ANOVA was
performed for data pre- and postlesion, for day and night
data and for a 24-hour period. Mesor HR values were
compared statistically for all animals using 2-way repeated
analysis of variance by surgery type (6-OHDA n = 6a n d
Sham lesioned n = 4) and pre/postlesion measures for
both day and night recordings. However, there were too
SNc
(a)
(a)
SNc
(b)
(b)
Figure 2: Photomicrographs of tyrosine hydroxylase immuno-
stained nigra of a control (a) and 6-OHDA lesioned (b) rat. Images
are representative of the eﬀect of a saline/sham microinjection (a)
and 6-OHDA lesion (b) of the MFB on the SNc. The nigral DA
neuronsarehighlyTH-immunoreactive;notethelackofstainingon
the right side of (b), indicative of a large lesion of the dopaminergic
SNc. In contrast, there is preservation of the nigra on the targeted
(right) side in (a). MFB, medial forebrain bundle; SNc, substantia
nigra pars compacta.
few signiﬁcantly periodic results for statistical comparison of
either of the wave components, amplitude, and acrophase.
3. Results
3.1.AnimalNumbers. Fromthefortyanimalsthatwereused,
ten animals had to be excluded due to surgical complications
(n = 6; of these 4 developed infections of the abdominal
wound site associated with repetitive picking of stitches
and 2 developed respiratory infections; all of which were
euthanased) or inadequate 6-OHDA lesioning (n = 4w i t h
<70% nigral cell loss; see below). This left 8 × 6-OHDA
lesioned, 6 sham lesioned (all rats in these groups received
telemetry implants) and 16 normal (unoperated cagemate)
rats.
3.2. Quantiﬁcation of Lesions. Analysis of TH-immuno-
reactivity in the SN (see Figure 2) indicated that eight of 12
lesioned with 6-OHDA had complete lesions. Sham-lesioned
rats(n = 6)hadnosigniﬁcantnigralcelllossandcresylviolet
staining conﬁrmed correct MFB targeting.
3.3. Behavioral Testing. All animals (implanted and cage-
mates) were tested prior to telemetry surgery, and no
diﬀerences were found between groups in all behavioralParkinson’s Disease 5
tests. No diﬀerences were found following telemetry surgery,
showing that implantation of the device had no inﬂuence
on the behavioral tests. After MFB surgery, there remained
no diﬀerence between sham surgery (saline-injected n = 6)
and untreated normal cagemates (n = 16), therefore data for
these two groups was pooled (n = 22 controls) for analysis
of behavioral testing data. There was a marked diﬀerence
between the 6-OHDA lesion animals versus pooled control
group in all four behavioral tests.
3.3.1. Behavioral Conﬁrmation of Parkinsonism after
6-OHDA Lesions
(1)PosturalMeasures. AfterMFBsurgery,thepooledcontrol
g r o u pc o n t i n u e dt oe x h i b i tn oh e a dp o s i t i o no rb o d ya x i s
bias, whereas there was a marked ipsilateral bias in these
parameters in the 6-OHDA lesioned group (see Figure 3).
For the apomorphine rotation test, a marked contralateral
turning bias was seen in the 6-OHDA lesion group whereas
no rotational asymmetry was noted in the pooled control
group (Figure 3).
(2) Sensorimotor Tests. Whilst 6-OHDA lesion rats did not
exhibit a signiﬁcant increase in sensorimotor neglect in the
simple task on either side after MFB surgery (data therefore
not shown) there was prominent contralateral slowing in
response time to tactile stimulation in the disengage test
relative to pooled controls (ANOVA: F = 16.594, P<. 0001,
post hoc: P<. 0001).
3.4. Telemetry Data. Telemetric data was derived from all
14 rats with successfully targeted MFB surgery. Data from
a subset of ten operated rats (six, 6-OHDA lesioned and
four sham lesioned) was used for further HRV and circadian
analysis as a result of technical problems with acquisition in
four rats.
3.4.1. Diurnal Rhythm. After telemetric implantation, pre-
lesion data was taken when recovery of HR and body
temperature reached levels comparable with the baseline
in the lesioned rats. Post-MFB surgery data was therefore
taken from day 4 after surgery until approximately day
12–14 (Figure 4). There was no signiﬁcant change in LA
(Figure 4(a))o rc B T( Figure 4(b)). However, there was a
lower diurnal rhythm of HR for 6-OHDA lesion rats than
sham-operated controls (Figure 4(c)). For the night and day
diurnal rhythm data, there was an overall decrease in HR
after MFB surgery. While there was a similar decrease in HR
for both groups during the day (by 19b.p.m. for 6-OHDA
lesion rats, relative to 21b.p.m. for sham-operated controls),
there was much greater decrease in HR (approximately two-
fold)frombaselineforthe6-OHDAlesionedratsinthenight
compared to sham-operated controls (by 38b.p.m. versus
17b.p.m., resp., P<. 05).
3.4.2. Heart Rate Variability. Data was compared for night
and day recordings (12:12 h) for pre- and postlesion, and for
24 hours recordings pre- and postlesion (data taken between
11–14 days after telemetry surgery and MFB surgery). Night
Table 1: Average mesor level heart rate values (± SEM) for the two
groups. BPM = beats/min.
Average Mesor Level Heart Rate (BPM)
Sham 6-OHDA
Prelesion 24 hr 378 ± 10 367 ± 6
Post lesion 24 hr 345 ± 12 364 ± 7
versusdayrecordingswerenotsigniﬁcantlydiﬀerentbetween
surgery groups. However, analysis of the 24 hours recordings
revealed diﬀerences in time domain and spectral parameters.
(1) Time Domain Parameters. There was a similar decrease
in average HR after MFB surgery in both groups. 6-OHDA
lesion rats had a decrease in mean HR of 20b.p.m. from pre-
lesion to postlesion which was similar to controls which had
a decrease of 30b.p.m. (average HR in 24 hours recording,
pre- versus postlesion: ANOVA: F = 32.522, P = .0005; post
hoc:P = .7183).Therewasacorrespondingincreaseinmean
NN interval (pre- versus postlesion: ANOVA: F = 29.044,
P = .0007; post hoc: P = .6565) and SDNN values for both
surgery groups (pre- and postlesion: ANOVA: F = 8.852,
P = .0177; post hoc: P = .9005; data not shown), indicating
that this was a time eﬀect. There was no signiﬁcant change in
RMSSD values in both surgery groups after MFB surgery.
(2) Spectral Analysis. Fast fourier transform spectral analysis
was performed on ECG recordings from sham control and
6-OHDA lesioned rats. There was no signiﬁcant diﬀerence in
pre- and postlesion data for the total power, VLF, LF or HF
components of the spectrum. There was a similar increase in
meanLF:HFratioinbothgroupsafterMFBsurgery(LF:HF
ratio for 24 hours recordings, pre- and postlesion:ANOVA:
F = 9.574, P = .0148; post hoc: P = .9608; data not shown).
(3) Chronobiological Analysis of Heart Rate. Fast Fourier
spectrum analysis revealed a dominant frequency corre-
sponding to a approximately a 24-hour wavelength in >90%
of the 24-hour datasets where periodicity was present.
Signiﬁcantperiodicityoccurredin7/12(58%)and5/8(63%)
of the 24 hours periods sampled in the 6-OHDA lesioned
and sham-operated groups, respectively. An example of a
ﬁtted curve for a representative rat which exhibited such
periodicity is given in Figure 5.
When examining 24-hour recordings from the two
surgical groups, a signiﬁcant drop in mesor for HR was
evident in sham-operated rats (ANOVA: F = 12.75, P<
.05), unlike 6-OHDA lesioned rats, when compared to the
prelesion state (Table 1).
4. Discussion
4.1. General Observations. There was a greater decrease in
HR diurnal rhythm for unilateral 6-OHDA lesioned rats
(relative to the controls), consistent with that reported in the
bilateral 6-OHDA animal model of PD [14]. This reﬂected
a lower nocturnal HR in hemiparkinsonian rats. There was6 Parkinson’s Disease
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Figure 3: Behavioral parameters. (a) Apomorphine rotation test. Net contralateral turning bias recorded as number of turns made in a 30
minutes period. Apomorphine induced an overt contralateral turning bias in the 6-OHDA lesioned group, but had no eﬀect on the pooled
control group, which did not exhibit rotation (unpaired t-test: t = 6.349, ∗∗∗P<. 0001). (b) Head position bias. There was no bias prior to
MFB surgery. 6-OHDA lesions induced an ipsilateral bias in head position in contrast to pooled controls which showed no bias (head bias
ANOVA: F = 6.983, P = .0003, post hoc group diﬀerence P = .0006). ∗∗P<. 001. (c) Curling severity and (d) direction of bias. There was
no bias at the baseline. 6-OHDA lesions induced an ipsilateral bias in curling in contrast to pooled controls which showed negligible bias
(curling severity ANOVA: F = 79.872, P<. 0001; post hoc group diﬀerence P<. 0001; curling bias ANOVA: F = 3.400, P = .0215; post
hoc group diﬀerence P = .0398). Vertical bars indicate mean ± SE of each group. BLN, baseline; MFB, medial forebrain bundle. Post Tel,
posttelemetry device implantation. Wk 1, Wk 2, weeks 1 and 2 after MFB surgery, respectively. ∗∗∗P<. 0001; ∗P<. 05.
also a generalized eﬀect of surgery on HR in both sham
control and lesioned groups following MFB surgery.
The behavioral data was consistent with previous studies
of parkinsonism in the unilateral 6-OHDA animal model
of PD. Large unilateral depletions of nigrostriatal DA in
rats leads to ipsilateral biases in the curling and head
position tests [13, 21, 29, 30], contralateral deﬁcits in
the disengage task [13, 31], and marked contralateral
apomorphine-induced rotation [32], suggesting that the rats
were adequately lesioned. The degree of lesioning was also
consistentwithwhatwehavepreviouslyobservedinthesame
gender and strain of rats, providing internal consistency
between studies [13]. Furthermore, there was an almost
complete loss of DA nigral neurons in 6-OHDA lesionedParkinson’s Disease 7
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Figure 4: Circadian rhythm data. Normalised data for amplitude
values were calculated as post-MFB surgery values as a percentage
ofmeanprelesion(BLN,baseline)dataforthecircadianparameters
of: LA (a), cBT (b), and HR (c), for sham-operated controls and 6-
OHDAlesionedrats.DatawastakenfromthedayafterMFBsurgery
(day 2) until 12–14 days after surgery. Data was analysed from
day 4, when recovery of HR and body temperature reached levels
comparable with the baseline in the lesioned rats. There was no
signiﬁcant change in LA (a) or cBT (b) between groups. However,
there was a lower diurnal rhythm of HR for 6-OHDA lesion rats
than sham-operated controls (ANOVA: F = 12.280, P = .0057;
posthocgroupdiﬀerence ∗∗∗P<. 0001).Circlesrepresentcontrols;
boxes represent 6-OHDA lesioned rats. BT, body temperature, HR,
heart rate, LA, locomotor activity.
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Figure 5: Example of ﬁtted circadian rhythm in a representative rat
for 24-hour heart rate post-Sham surgery. Cosinor analysis revealed
signiﬁcant periodicity (P<. 05); with mesor = 372.2 (horizontal
line above), amplitude = 51.6, acrophase = 1 : 28 hours. bpm =
beats/min.
rats on the lesioned side. This ensured that the animal
model created was suﬃciently parkinsonian and therefore
appropriate for comparative telemetric analysis.
4.2. Choice of Model Relative to Other Studies. The novelty of
this project was that the (1) unilateral 6-OHDA rat model
of PD had never been used in a telemetric study of auto-
nomic dysfunction and (2) previous studies of autonomic
dysfunction have not targeted the MFB (i.e., the striatum
was lesioned bilaterally or the ventral tegmental area, VTA
itself was targeted [14, 15]). Given that the unilateral 6-
OHDA lesioning of the MFB is the model most commonly
used in PD research, it was of relevance to examine this
issue. Since there is no striatal neurodegeneration in PD
and the VTA (A10) is not the major site of dopaminergic
cell loss in patients [33], targeting the MFB produces an
animal model more likely to mimic nigral degeneration
and accompanying motor symptoms of PD than models
targeting either VTA or the striatum. Striatal DA depletion
from nigral degeneration leads to increased inhibition of
the motor thalamus, by causing glutamatergic subthalamic
hyperactivity and increased GABAergic transmission via
basalgangliaoutputnuclei(SNparsreticulata/medialglobus
pallidus) [34]. The decreased thalamocortical activation
produces the slowness of movement (bradykinesia) and
rigidity characteristic of PD [34]. A major ethical advantage
of the unilateral rat model used in this study is that the rats
suﬀerlessmorbidity(caneatanddrinkindependentlywithin
hoursofsurgery)andmortalitythanthebilateralmodel(i.e.,
can eat and drink independently within hours of surgery and
have 97% versus 50% survival rate, resp.) [35, 36].
4.3. Telemetry
4.3.1. Heart Rate. The main ﬁnding from telemetry was a
loweramplitudeofdiurnalrhythmforHRin6-OHDAlesion
rats compared to sham controls (i.e., the diﬀerence between8 Parkinson’s Disease
the day: night or light: dark cycle). This was due to the
decreasedHRof6-OHDAlesionratsduringtheirnight/wake
cycle. Ben and Bruguerolle [14] also found a decrease in
the amplitude for HR diurnal rhythm in four rats with
a double bilateral 6-OHDA lesion of the striatum relative
to three sham-operated controls during telemetry for three
weeks postoperatively [14]. However, there was >30% loss
of body weight in the parkinsonian rats suggesting poorer
healthwhich could adversely impact on autonomic measures
[14]. The dopaminergic innervation of the striatum was
aﬀected in the present study by the lesion of the nigrostriatal
tract. Both studies suggest a relationship between the loss
of DA in the striatum and the control of HR. Previous
studies have found evidence to support a direct association
between the nigrostriatal system and cardiovascular function
[37–39]. Electrical [40]o rc h e m i c a l[ 41] stimulation of
the SN pars compacta in rats enhanced DA release in
the striatum and elicited proportional hypertension and
tachycardia. Furthermore, other studies injected various
tachykininagonistsbilaterallyintotheSNparscompactaand
found that in awake, unrestrained rats tachycardia occurred
[42], whereas in spontaneously hypertensive rats tachycardia
and mean arterial pressure increased [43]. In addition,
high frequency deep brain stimulation of the nigra during
neurosurgery in PD patients was associated with increased
heart rate and blood pressure [44]. These combined data
support a role for nigral regulation of both cardiovascular
parameters. It could therefore be inferred that loss of DA in
this area could lead to hypotension and decreased HR, that
is, a decrease of sympathetic innervation in the heart, which
are both cardiovascular features of PD [45] .T h ed e c r e a s ei n
the HR for the wake cycle of the 6-OHDA lesion rats may be
due to ﬂuctuations in DA metabolism or DA accumulation
during the day/sleep cycle, which is a suggested reason for
diurnal ﬂuctuations in parkinsonian symptoms [46].
Apart from the larger decrease (approximately two-fold
greater) in HR for 6-OHDA lesion rats, after MFB surgery
HR was somewhat lower for both surgical groups, for both
night and day. This indicates that there not only was there
a substantial eﬀect of DA cell loss, but there was also a
general eﬀect of the surgery itself on HR. Previous research
has shown that surgery can blunt the amplitude of diurnal
rhythms with the eﬀects on HR and cBT lasting for 12–15
days [47]. This could explain the subtle drop in BT during
the day in both groups after MFB surgery. One study [48]
monitored the eﬀect of anaesthesia (ketamine or ether) via
t e l e m e t r ya n df o u n da ne ﬀect on diurnal rhythmicity for 7–
10 days [48]. Since our surgical groups were matched for
anaesthesia type, this factor is unlikely to account for the
greater nocturnal decrease in HR in parkinsonian rats but
may contribute to the generalized postoperative decrease in
HR found in both groups.
4.3.2. Core Body Temperature. Whilst thermoregulatory dys-
f u n c t i o nh a sb e e nr e p o rt e di nP Dp a t i e n t s[ 8], a recent paper
speciﬁcally examining this issue found that patients with
idiopathic PD exhibited a nocturnal fall in cBT similar to
controls,whereasparkinsonianpatientswithmultiplesystem
atrophy exhibited an abnormal response [49]. In the present
study, whilst there was no overall diﬀerence between the 6-
OHDA versus sham-lesioned rats from day four, in the ﬁrst
couple of days postoperatively a lower cBT was evident in
the 6-OHDA lesioned rats (Figure 4(a)). A previous study
also noted a transient drop in cBT for a few days after
bilateral striatal lesions accompanied by a loss of periodicity
of the circadian rhythm for this parameter for a month
postoperatively [14].
4.3.3. Locomotor Activity. No signiﬁcant eﬀect was found in
the amplitude of the diurnal rhythm of locomotor activity
following MFB lesioning, similar to the bilateral lesion rat
model [14]. This contrasts with another study reporting that
LA itself was suppressed following a lesion to the ventral
tegmental area (VTA) [15]. Diﬀerences in surgical targeting
may account for this.
4.3.4. Heart Rate Variability. The signiﬁcantly altered HRV
in both groups after MFB surgery, indicates a general eﬀect
of surgery on cardiovascular function, at least in the ﬁrst
fortnight after surgery. Analysis of HRV has been found
to be an eﬀective indirect measure of variability in ANS
activity [50]. HRV describes both instantaneous heart rate
and the beat-to-beat heart rate signal (R-R interval) [27].
Lower variability is often an indicator of abnormal and
insuﬃcient adaptability of the ANS, implying the presence of
a physiological malfunction [51]. PD patients exhibiting car-
diovascular complications have decreased HRV [52]w h i c hi s
a sensitive and speciﬁc predictor of mortality [53].
4.3.5. Time and Frequency Domain Analysis. In the time
domain analysis, there was a notable increase in the HRV
parameters of mean NN interval and SDNN (as compared to
baseline) reﬂecting a shift of sympathovagal balance towards
a parasympathetic prevalence [54]. For frequency domain
analysis, there was a marked increase in the LF/HF ratio,
suggesting a predominance of sympathetic rather than vagal
activity (LF is mediated by sympathetic activity; HF is
parasympatheticactivity)[8].Thisapparentconﬂictbetween
time-domain and frequency domain analyses has also been
observed in unrestrained rats and it has been suggested
that frequency domain measures are more suitable for
investigating parasympathetic and sympathetic interactions
in the rat [20]. It is also generally agreed that initial
cardiovascular symptoms of PD are parasympathetic in
nature, and both sympathetic and parasympathetic at later
stages of the disease [55]. The unilateral 6-OHDA model
used would approximate advanced PD (where there is >90%
DA cell loss).
4.3.6.Chronobiology Analysis. Whilst chronobiology analysis
was not a major focus of the present study, a subanalysis of
telemetry data for heart rate was attempted for comparative
purposes [14]. Since approximately 40% of 24-hour samples
analysed did not exhibit evidence of periodicity, this limited
the analysis. However where present, this approximated a
circadian (24 hours) pattern. Whilst a signiﬁcant eﬀect(drop
in mesor for HR) was evident when comparing pre- versusParkinson’s Disease 9
post-MFB surgery conditions in sham-operated rats, this
was not evident in 6-OHDA-lesioned rats. The discrepancy
between this and the lower amplitude of diurnal rhythm in
HR in the 6-OHDA lesioned rats, relative to sham-operated
controls is probably accounted for by the diﬀerent nature
of data analysis techniques (mesor versus mean; 24 hours
versus day and night data), small numbers of rats and
lack of periodicity in approximately 40% of the recordings.
The latter probably also explains why we could not detect
a signiﬁcantly lower mesor for HR in 6-OHDA lesioned
animals compared to a previous study [14].
Overallthisstudyestablishedthattheunilateral6-OHDA
model of PD displayed subtle cardiovascular autonomic
dysfunction with reduced nocturnal HR. Where periodicity
was present, it followed a 24-hour circadian rhythm for HR.
Further studies are required to explore the chronicity of this
phenomenon and eﬀects of dopaminergic therapy.
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